INTRODUCTION
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impressive diversity of his contributions to the fi eld. He was a giant among us whose scholarly impact spanned 40 years and over 500 published works encompassing not only substance use and abuse, criminology and criminal justice, but also public policy, HIV/AIDS, medicine, and law. Several of his seminal papers and books set the stage for ongoing research into crack cocaine use, drug policy, HIV risk among vulnerable populations, and the effectiveness of prison-based substance abuse treatment for drug-involved offenders. This special issue of the Journal of Drug Issues is dedicated to his unparalleled work in the substance abuse fi eld and to the memory of this exceptional man.
Jim's professional body of work refl ects his dedication to building scientifi c knowledge in the fi eld, and his deeply held belief that this knowledge be applied to improve the lives of individuals impacted by substance abuse. The breadth of original work in Jim's portfolio included 21 projects on which he served as the Principal Investigator. The scope of this work is a testament to his long standing commitment to the fi eld of drug research, including the complex contextual and structural relationships to institutions and cultures.
In recognition of his extraordinary contributions, Jim received numerous awards, including those from the American Society of Criminology, the Academy of Criminal Justice Sciences, and the Drug and Alcohol Section of the American Sociological Association. He was an active member of the College on Problems of Drug Dependence, and a former member of the President's Advisory Committee for Offi ce of National Drug Control Policy. In 1994, he received the Outstanding Scholar Award from the University of Delaware, and in 1995 he was made a Fellow of the American Society of Criminology. For his ground-breaking work in correctionsbased therapeutic community treatment, Jim was honored with a prestigious Merit Award from the National Institute on Drug Abuse in 1995.
The original papers developed for this special issue of Journal of Drug Issues reflect Jim's diverse research interests ranging from drug treatment impact, corrections-based treatment, international HIV prevention interventions, substance use epidemiology, prescription drug diversion, and drug policy.
Two of the papers focus on one of Jim's major contributions to the fi eld: breaking the drugs-crime relationship through treatment interventions with offender populations. Steve Martin and colleagues extend Jim's research on the therapeutic community (TC) continuum of treatment for drug-involved offenders by conducting analyses to examine the effects of TC treatment on the long-term success of offenders up to 18 years after release from prison. Michele Staton-Tindall and colleagues present outcomes following prison-and jail-based treatment among reentering women offenders from the Criminal Justice Kentucky Treatment Outcome Study and provide an exploratory look at differences in sustained abstinence, community treatment utilization, and recidivism by geographic location (metropolitan vs. nonmetropolitan) and treatment program (jail or prison). Together, these two papers support the work Jim began by documenting the feasibility of offering treatment services to criminal justice populations and the effectiveness of treatment in reducing both relapse to drug use and criminal recidivism among this population.
Jim was one of the fi rst drug abuse researchers to understand that drug use patterns in the United States were inexorably related to global drug policy and drug use patterns. Two papers present outcomes from international settings, which refl ect Jim's interest and commitment to international research. Building on Jim's work with club drug users in South Florida, Flavio Pechansky and colleagues present data on the use of ecstasy and LSD in Brazil, where there is limited information on the use of club drugs among young, middle-class club goers. Wendee Wechsberg and colleagues present the fi ndings from a community-based randomized trial that assessed the effi cacy of an adapted evidence-based Woman-Focused HIV intervention, addressing three concurrent epidemics in South Africa: HIV, substance use, and gender-based violence with sex workers and non-sex workers. This research closely parallels Jim's Miami-based research involving HIV interventions for highly vulnerable women.
For three decades, Jim played an active part in the national and international drug policy debate. With a high profi le generated by a series of frequently reprinted monographs and articles deliberating drug policy, Jim often took a certain joy in noting the illogic and polemics of the different policy positions. Duane McBride coauthored many such works with Jim, and he continues this work on drug policy analysis in this special issue. McBride and colleagues focus on the possible effects of state-level policies implemented in the middle of the past decade in reaction to a rapid increase in small toxic lab (STL) production of methamphetamine and examine the policy development and the policy components that appear to relate to reduced STL production.
Very early in his career, Jim was responsible for monitoring data related to drug overdoses in a NIDA funded project in Miami, Florida. As early as the 1970s, he noted that many overdose cases involved the misuse of prescription drugs. Continuing this line of research over the years, Jim established an active research portfolio examining the diversion of prescription medications and the impact on public health. Using some of the fi rst systematic data on this topic from two large studies-a national sample of opioid treatment clients and a South Florida study targeting diverse populations of opioid abusers-Ted Cicero and colleagues describe mechanisms of prescription opioid diversion by examining abusers' sources of diverted drugs and raise important implications for drug diversion control.
We hope that this special issue of Journal of Drug Issues, dedicated to the memory and legacy of Jim Inciardi, will remain a lasting tribute to his belief in the
